Analysis of the Cytosolic Proteome in a Cell Culture Model of Familial Amyotrophic Lateral Sclerosis Reveals Alterations to the Proteasome, Antioxidant Defenses, and Nitric Oxide Synthetic Pathways-Reference-Cited by-同舟云学术

Analysis of the Cytosolic Proteome in a Cell Culture Model of Familial Amyotrophic Lateral Sclerosis Reveals Alterations to the Proteasome, Antioxidant Defenses, and Nitric Oxide Synthetic Pathways

Published:2003-02 Issue:8 Volume:278 Page:6371-6383
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Allen Simon,Heath Paul Roy,Kirby Janine,Wharton Stephen Barrie,Cookson Mark Robert,Menzies Fiona Mhairi,Banks Rosamonde Elizabeth,Shaw Pamela Jean

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference74 articles.

1. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

2. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity.

3. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury

4. Transgenic-Mouse Model of Amyotrophic Lateral Sclerosis

5. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidative Cysteine Post Translational Modifications Drive the Redox Code Underlying Neurodegeneration and Amyotrophic Lateral Sclerosis;Antioxidants;2024-07-23

2. Small molecules targeting different cellular pathologies for the treatment of amyotrophic lateral sclerosis;Medicinal Research Reviews;2023-05-26

3. Blood–Brain Barrier Disruption and Its Involvement in Neurodevelopmental and Neurodegenerative Disorders;International Journal of Molecular Sciences;2022-12-03

4. Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosis;Expert Review of Proteomics;2021-11-02

5. Targeting Abnormal Nrf2/HO-1 Signaling in Amyotrophic Lateral Sclerosis: Current Insights on Drug Targets and Influences on Neurological Disorders;Current Molecular Medicine;2021-10